Similarly, patients with non-ST segment elevation myocardial infarction (NSTEMI) and a high SYNTAX score (used for assessing the severity of CAD) had significantly lower serum adropin levels compared with NSTEMI patients with a low SYNTAX score (Ertem et al., 2017). The gene discussed is ENHO; the disease is coronary artery disorder.